Bausch Health Co. Inc. (BHC) Misses Q2 EPS by $1.29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS
August 9, 2022 7:00 AM EDTRevenues of $1.967 billionCompany to appeal anticipated court decision and vigorously defend XIFAXAN intellectual propertyBalance sheet continues to improve with early retirement of $481 million of long-term debt through open market repurchasesCommitted to strategic alternatives and will continue to evaluate the distribution of Bausch + Lomb shares as the Company works through patent litigationUpdates guidance
LAVAL, QC, Aug. 9, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX:... More
